CN106924456A - One kind is for activating mitochondrial composition - Google Patents
One kind is for activating mitochondrial composition Download PDFInfo
- Publication number
- CN106924456A CN106924456A CN201710204579.7A CN201710204579A CN106924456A CN 106924456 A CN106924456 A CN 106924456A CN 201710204579 A CN201710204579 A CN 201710204579A CN 106924456 A CN106924456 A CN 106924456A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- powder
- extract
- steam explosion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 230000003213 activating effect Effects 0.000 title claims abstract description 15
- 230000002438 mitochondrial effect Effects 0.000 title abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 36
- 210000003470 mitochondria Anatomy 0.000 claims abstract description 22
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 14
- 235000009566 rice Nutrition 0.000 claims abstract description 14
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 12
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 12
- 229940096421 milk thistle extract Drugs 0.000 claims abstract description 12
- 235000020727 milk thistle extract Nutrition 0.000 claims abstract description 12
- 229940114496 olive leaf extract Drugs 0.000 claims abstract description 12
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 12
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 7
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 7
- 238000000855 fermentation Methods 0.000 claims abstract description 7
- 230000004151 fermentation Effects 0.000 claims abstract description 7
- 235000007689 Borago officinalis Nutrition 0.000 claims abstract description 6
- 241000723418 Carya Species 0.000 claims abstract description 6
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims abstract description 6
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims abstract description 6
- 229920002079 Ellagic acid Polymers 0.000 claims abstract description 6
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims abstract description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001009 acetylcarnitine Drugs 0.000 claims abstract description 6
- 229960002852 ellagic acid Drugs 0.000 claims abstract description 6
- 235000004132 ellagic acid Nutrition 0.000 claims abstract description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 6
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001285 quercetin Drugs 0.000 claims abstract description 6
- 235000005875 quercetin Nutrition 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 240000007594 Oryza sativa Species 0.000 claims abstract 4
- 240000004355 Borago officinalis Species 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000004880 explosion Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 18
- 239000002244 precipitate Substances 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 9
- 229920005989 resin Polymers 0.000 claims description 9
- 241000222336 Ganoderma Species 0.000 claims description 8
- 108090000145 Bacillolysin Proteins 0.000 claims description 6
- 102000035092 Neutral proteases Human genes 0.000 claims description 6
- 108091005507 Neutral proteases Proteins 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000007858 starting material Substances 0.000 claims description 5
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 3
- 240000007817 Olea europaea Species 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 241000320380 Silybum Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 235000008476 powdered milk Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000005515 coenzyme Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract description 5
- 229940110767 coenzyme Q10 Drugs 0.000 abstract description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract description 5
- 108020005196 Mitochondrial DNA Proteins 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 206010034010 Parkinsonism Diseases 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 208000015122 neurodegenerative disease Diseases 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 241000209094 Oryza Species 0.000 description 10
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 4
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4
- 241001072256 Boraginaceae Species 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 108091093105 Nuclear DNA Proteins 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 1
- YPZRHBJKEMOYQH-UYBVJOGSSA-L FADH2(2-) Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-L 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000012268 mitochondrial disease Diseases 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000015607 signal release Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于激活线粒体的组合物,由以下重量份的原料制备而成:香豆雌酚10‑20份、辅酶Q10 5‑10份、鞣花酸10‑20份、槲皮素1‑3份、葡萄籽提取物5‑10份、奶蓟草提取物10‑15份、橄榄叶提取物10‑15份、琉璃苣10‑15份、葛仙米发酵粉3‑6份、破壁灵芝孢子粉4‑8份、乙酰肉碱10‑15份、山核桃树皮超微粉碎粉5‑10份。本发明所得组合物可提高线粒体酶的活性和增加线粒体DNA的数量,所以所述组合物能激活线粒体并增加线粒体的生物合成。因此,所述本发明组合物可有效用于预防或治疗各种与线粒体活性降低有关的疾病,如退化性疾病、帕金森综合症等。The invention discloses a composition for activating mitochondria, which is prepared from the following raw materials in parts by weight: 10-20 parts of coumestrol, 5-10 parts of coenzyme Q10, 10-20 parts of ellagic acid, quercetin 1-3 parts of vegetable, 5-10 parts of grape seed extract, 10-15 parts of milk thistle extract, 10-15 parts of olive leaf extract, 10-15 parts of borage, 3-6 parts of kudzu rice fermentation powder , 4‑8 parts of Ganoderma lucidum spore powder, 10‑15 parts of acetylcarnitine, 5‑10 parts of superfine hickory bark powder. The composition obtained in the present invention can improve the activity of mitochondrial enzymes and increase the quantity of mitochondrial DNA, so the composition can activate mitochondria and increase biosynthesis of mitochondria. Therefore, the composition of the present invention can be effectively used for the prevention or treatment of various diseases associated with decreased mitochondrial activity, such as degenerative diseases, Parkinson's syndrome and the like.
Description
技术领域technical field
本发明具体涉及一种用于激活线粒体的组合物。The present invention specifically relates to a composition for activating mitochondria.
背景技术Background technique
线粒体是一种可在绝大多数真核细胞中发现的细胞器。线粒体具有自己的DNA,即独立于细胞核DNA之外的DNA(mtDNA)。Mitochondria are organelles found in the vast majority of eukaryotic cells. Mitochondria have their own DNA, DNA (mtDNA) that is separate from the nuclear DNA.
线粒体最重要的作用是生成三磷酸腺苷(ATP),ATP是细胞内的能量来源。用线粒体基质内产生的NADH和FADH2、通过TCA循环(三羧酸循环)、从电子传递链产生ATP。因此,产生的ATP是用来激活各种需要能量的生物合成和代谢过程。The most important role of mitochondria is to generate adenosine triphosphate (ATP), which is the energy source in cells. ATP is produced from the electron transport chain through the TCA cycle (tricarboxylic acid cycle) using NADH and FADH2 produced in the mitochondrial matrix. Thus, the ATP produced is used to activate various biosynthetic and metabolic processes requiring energy.
线粒体还可在基质中短暂地储存钙离子,钙离子对于细胞内信号转导非常重要,并且当需要时又能将钙离子释放到细胞质中。此外,已知线粒体在细胞凋亡、细胞增殖和细胞代谢等活动中起着中央调控作用。Mitochondria also transiently store calcium ions in the matrix, which are important for intracellular signal transduction, and release calcium ions into the cytoplasm when needed. In addition, mitochondria are known to play central regulatory roles in activities such as apoptosis, cell proliferation, and cell metabolism.
线粒体的DNA相对易受到损坏,因为它与细胞核DNA不同,缺乏自身修复机制,且没有保护DNA的组蛋白。众所周知,线粒体DNA的损坏与线粒体疾病的发病密切相关。线粒体功能的退化,会导致细胞活动所需能量来源ATP合成的减少,从而引起各种疾病。Mitochondrial DNA is relatively vulnerable to damage because, unlike nuclear DNA, it lacks self-repair mechanisms and has no DNA-protecting histones. It is well known that the damage of mitochondrial DNA is closely related to the pathogenesis of mitochondrial diseases. The degradation of mitochondrial function will lead to the reduction of ATP synthesis, which is an energy source required for cell activities, and thus cause various diseases.
发明内容Contents of the invention
为解决上述问题,本发明提供了一种用于激活线粒体的组合物。To solve the above problems, the present invention provides a composition for activating mitochondria.
为实现上述目的,本发明采取的技术方案为:In order to achieve the above object, the technical scheme that the present invention takes is:
一种用于激活线粒体的组合物,由以下重量份的原料制备而成:A composition for activating mitochondria, prepared from the following raw materials in parts by weight:
香豆雌酚10-20份、辅酶Q10 5-10份、鞣花酸10-20份、槲皮素1-3份、葡萄籽提取物5-10份、奶蓟草提取物10-15份、橄榄叶提取物10-15份、琉璃苣10-15份、葛仙米发酵粉3-6份、破壁灵芝孢子粉4-8份、乙酰肉碱10-15份、山核桃树皮超微粉碎粉5-10份10-20 parts of coumestrol, 5-10 parts of coenzyme Q10, 10-20 parts of ellagic acid, 1-3 parts of quercetin, 5-10 parts of grape seed extract, 10-15 parts of milk thistle extract , 10-15 parts of olive leaf extract, 10-15 parts of borage, 3-6 parts of kudzu rice fermentation powder, 4-8 parts of broken Ganoderma lucidum spore powder, 10-15 parts of acetyl carnitine, hickory bark super 5-10 parts of finely pulverized powder
其中,所述葡萄籽提取物通过以下步骤制备所得:Wherein, the grape seed extract is prepared through the following steps:
S1、将葡萄籽盐水浸泡0.5~1小时后,置于闪式提取器处理内,闪式处理后,加入3~6倍水,按质量百分比为0.5~1.5%的比例加入中性蛋白酶,30~40℃下酶解0.5~2h,过滤,得酶解液;S1. After soaking the grape seeds in salt water for 0.5-1 hour, place them in a flash extractor for treatment. After the flash treatment, add 3-6 times of water, and add neutral protease in a proportion of 0.5-1.5% by mass, 30 Enzymolyze at ~40°C for 0.5~2h, filter to obtain enzymolyzate;
S2、将酶解液直接通过中性氧化铝柱,树脂柱径高比为1∶6~1∶11,分别用1~3倍柱体积水、1~2倍柱体积95%的有机溶液洗脱除杂,用6~10倍柱体积的0.3~0.7%冰醋酸~50%的有机溶剂(1∶1)溶液洗脱,收集洗脱液;S2, the enzymolysis solution is directly passed through the neutral alumina column, and the diameter-to-height ratio of the resin column is 1:6 to 1:11, and washed with 1 to 3 times of the column volume of water and 1 to 2 times of the column volume of 95% organic solution respectively Remove impurities, elute with 0.3-0.7% glacial acetic acid-50% organic solvent (1:1) solution of 6-10 times column volume, and collect the eluate;
S3、将洗脱液浓缩干燥,得葡萄籽提取物。S3, concentrating and drying the eluate to obtain grape seed extract.
其中,所述奶蓟草提取物通过以下步骤制备所得:Wherein, the milk thistle extract is prepared through the following steps:
将干燥的奶蓟草用闪式提取器处理,所得提取液先用武火加热,沸腾后用文火加热1-1.5h,过滤浓缩至1.5g/ml,缓慢加入90-100%乙醇,直至乙醇浓度为55-65%,冷藏8-9小时,2000-4000r/min离心15-25min后倒去上清液,沉淀用去离子水溶解至原体积,用乙醇沉淀2次,乙醇浓度分别为65-75%、75-85%;沉淀用去离子水溶解至原体积,加入1/6-1/5体积10-12%的三氯乙酸溶液,充分混匀后静置4-6h,2000-4000r/min离心15-25min后去沉淀得上清液,将所得上清液抽滤,烘干,得奶蓟草提取物。Treat the dried milk thistle with a flash extractor, heat the obtained extract first with strong fire, then heat with slow fire for 1-1.5h after boiling, filter and concentrate to 1.5g/ml, slowly add 90-100% ethanol until the concentration of ethanol is reached 55-65%, refrigerated for 8-9 hours, centrifuged at 2000-4000r/min for 15-25min, poured off the supernatant, dissolved the precipitate with deionized water to the original volume, and precipitated with ethanol twice, the ethanol concentration was 65- 75%, 75-85%; dissolve the precipitate with deionized water to the original volume, add 1/6-1/5 volume of 10-12% trichloroacetic acid solution, mix well and let stand for 4-6h, 2000-4000r After centrifuging for 15-25min at 15-25min, the supernatant was obtained by removing the precipitate, and the obtained supernatant was suction-filtered and dried to obtain the milk thistle extract.
其中,所述橄榄叶提取物通过以下步骤制备所得:Wherein, the olive leaf extract is prepared through the following steps:
取橄榄叶清洗后冷冻干燥,打碎,解冻后室温浓缩至相对密度1.10-1.20,喷雾干燥浓缩液后,进行CO2超临界萃取,流体萃取压力为30-50MPa,萃取温度30-40℃,CO2流体流量为750-850L/h,萃取时间为3-5h,得橄榄叶提取物。Wash the olive leaves, freeze-dry them, crush them, thaw them at room temperature and concentrate them to a relative density of 1.10-1.20, spray-dry the concentrated solution, and perform CO2 supercritical extraction. The fluid extraction pressure is 30-50MPa, and the extraction temperature is 30-40°C. The CO 2 fluid flow rate is 750-850L/h, and the extraction time is 3-5h to obtain olive leaf extract.
其中,所述葛仙米发酵粉通过以下步骤制备所得:Wherein, the kudzu rice fermented powder is prepared through the following steps:
取洗净沥干后的葛仙米置于汽爆罐内,先通入氮气至汽爆罐内压力为0.7-1.5MPa,爆破处理7-23min;然后迅速通入蒸汽至汽爆罐内压力为1.5-2.1MPa,蒸汽爆破处理0.8-2.8min后,按照接种量1.5-1.7%的比例接种微生物发酵剂,保持温度25-35℃,发酵48-54小时后,高温灭菌,得葛仙米发酵粉。Take the washed and drained kudzu rice and put it in the steam explosion tank, first pass nitrogen gas until the pressure in the steam explosion tank is 0.7-1.5MPa, and blast for 7-23 minutes; then quickly inject steam to the pressure in the steam explosion tank 1.5-2.1MPa, after steam explosion treatment for 0.8-2.8min, inoculate the microbial starter according to the proportion of 1.5-1.7% of the inoculum, keep the temperature at 25-35°C, ferment for 48-54 hours, and then sterilize at high temperature to obtain kudzu Rice Baking Powder.
其中,所述微生物发酵剂由乳酸杆菌、地衣芽孢杆菌、谷氨酸棒杆菌按质量比3∶2∶1混合所得。Wherein, the microbial starter is obtained by mixing Lactobacillus, Bacillus licheniformis and Corynebacterium glutamicum in a mass ratio of 3:2:1.
其中,所述破壁灵芝孢子粉通过以下步骤制备所得:Wherein, the broken ganoderma spore powder is prepared through the following steps:
S1、将洗净沥干的灵芝孢子置于汽爆罐内,先通入氮气至汽爆罐内压力为0.6-1.4MPa,爆破处理8-25min;然后迅速通入蒸汽至汽爆罐内压力为1.4-1.8MPa,蒸汽爆破处理0.5-2.5min后,室温浓缩至相对密度1.10-1.20,喷雾干燥浓缩液,得粉体;S1. Put the washed and drained Ganoderma lucidum spores in the steam explosion tank, first feed nitrogen until the pressure in the steam explosion tank is 0.6-1.4MPa, and blast for 8-25 minutes; then quickly inject steam to the pressure in the steam explosion tank 1.4-1.8MPa, steam explosion treatment for 0.5-2.5min, concentrated at room temperature to a relative density of 1.10-1.20, spray-dried the concentrate to obtain powder;
S2、向粉体中加入3-8倍水,按质量百分比为2-3%的比例加入中性蛋白酶,按质量百分比为1-2%加入风味蛋白酶,30-50℃下酶解1-2h,过滤,得酶解液;S2. Add 3-8 times of water to the powder, add neutral protease at a mass percentage of 2-3%, add flavor protease at a mass percentage of 1-2%, and enzymatically hydrolyze at 30-50°C for 1-2 hours , filtered to obtain the enzymatic solution;
S3、将所得的发酵液迅速冷冻后再自然解冻,使提取物中淀粉老化沉淀;收集上清液,剩余部分离心,收集离心液体并合并于上清液中;S3, rapidly freezing the obtained fermented liquid and then thawing naturally to age and precipitate the starch in the extract; collecting the supernatant, centrifuging the remaining part, collecting the centrifuged liquid and merging it into the supernatant;
S4、将上清液以3-7BV/h的流速通过大孔树脂柱,动态吸附饱和后,用去离子水以5-8BV/h的流速淋洗上述大孔树脂柱至流出液无色,再用体积分数为50%-70%的有机溶剂以8-12BV/h的流速进行洗脱,收集洗脱液,冷冻干燥,得破壁灵芝孢子粉。S4. Pass the supernatant through the macroporous resin column at a flow rate of 3-7BV/h. After the dynamic adsorption is saturated, rinse the above-mentioned macroporous resin column with deionized water at a flow rate of 5-8BV/h until the effluent is colorless. Then use an organic solvent with a volume fraction of 50%-70% for elution at a flow rate of 8-12BV/h, collect the eluate, and freeze-dry to obtain the broken-wall ganoderma spore powder.
本发明具有以下有益效果:The present invention has the following beneficial effects:
所得组合物可提高线粒体酶的活性和增加线粒体DNA的数量,所以所述组合物能激活线粒体并增加线粒体的生物合成。因此,所述本发明组合物可有效用于预防或治疗各种与线粒体活性降低有关的疾病,如退化性疾病、帕金森综合症等。The resulting composition can increase the activity of mitochondrial enzymes and increase the amount of mitochondrial DNA, so the composition can activate mitochondria and increase mitochondrial biosynthesis. Therefore, the composition of the present invention can be effectively used for the prevention or treatment of various diseases associated with decreased mitochondrial activity, such as degenerative diseases, Parkinson's syndrome and the like.
具体实施方式detailed description
为了使本发明的目的及优点更加清楚明白,以下结合实施例对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the objects and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
以下实施例中,所使用的葡萄籽提取物通过以下步骤制备所得:In the following examples, the grape seed extract used is prepared through the following steps:
S1、将葡萄籽盐水浸泡0.5~1小时后,置于闪式提取器处理内,闪式处理后,加入3~6倍水,按质量百分比为0.5~1.5%的比例加入中性蛋白酶,30~40℃下酶解0.5~2h,过滤,得酶解液;S1. After soaking the grape seeds in salt water for 0.5-1 hour, place them in a flash extractor for treatment. After the flash treatment, add 3-6 times of water, and add neutral protease in a proportion of 0.5-1.5% by mass, 30 Enzymolyze at ~40°C for 0.5~2h, filter to obtain enzymolyzate;
S2、将酶解液直接通过中性氧化铝柱,树脂柱径高比为1∶6~1∶11,分别用1~3倍柱体积水、1~2倍柱体积95%的有机溶液洗脱除杂,用6~10倍柱体积的0.3~0.7%冰醋酸~50%的有机溶剂(1∶1)溶液洗脱,收集洗脱液;S2, the enzymolysis solution is directly passed through the neutral alumina column, and the diameter-to-height ratio of the resin column is 1:6 to 1:11, and washed with 1 to 3 times of the column volume of water and 1 to 2 times of the column volume of 95% organic solution respectively Remove impurities, elute with 0.3-0.7% glacial acetic acid-50% organic solvent (1:1) solution of 6-10 times column volume, and collect the eluate;
S3、将洗脱液浓缩干燥,得葡萄籽提取物。S3, concentrating and drying the eluate to obtain grape seed extract.
其中,所述奶蓟草提取物通过以下步骤制备所得:Wherein, the milk thistle extract is prepared through the following steps:
将干燥的奶蓟草用闪式提取器处理,所得提取液先用武火加热,沸腾后用文火加热1-1.5h,过滤浓缩至1.5g/ml,缓慢加入90-100%乙醇,直至乙醇浓度为55-65%,冷藏8-9小时,2000-4000r/min离心15-25min后倒去上清液,沉淀用去离子水溶解至原体积,用乙醇沉淀2次,乙醇浓度分别为65-75%、75-85%;沉淀用去离子水溶解至原体积,加入1/6-1/5体积10-12%的三氯乙酸溶液,充分混匀后静置4-6h,2000-4000r/min离心15-25min后去沉淀得上清液,将所得上清液抽滤,烘干,得奶蓟草提取物。Treat the dried milk thistle with a flash extractor, heat the obtained extract first with strong fire, then heat with slow fire for 1-1.5h after boiling, filter and concentrate to 1.5g/ml, slowly add 90-100% ethanol until the concentration of ethanol is reached 55-65%, refrigerated for 8-9 hours, centrifuged at 2000-4000r/min for 15-25min, poured off the supernatant, dissolved the precipitate with deionized water to the original volume, and precipitated with ethanol twice, the ethanol concentration was 65- 75%, 75-85%; dissolve the precipitate with deionized water to the original volume, add 1/6-1/5 volume of 10-12% trichloroacetic acid solution, mix well and let stand for 4-6h, 2000-4000r After centrifuging for 15-25min at 15-25min, the supernatant was obtained by removing the precipitate, and the obtained supernatant was suction-filtered and dried to obtain the milk thistle extract.
其中,所述橄榄叶提取物通过以下步骤制备所得:Wherein, the olive leaf extract is prepared through the following steps:
取橄榄叶清洗后冷冻干燥,打碎,解冻后室温浓缩至相对密度1.10-1.20,喷雾干燥浓缩液后,进行CO2超临界萃取,流体萃取压力为30-50MPa,萃取温度30-40℃,CO2流体流量为750-850L/h,萃取时间为3-5h,得橄榄叶提取物。Wash the olive leaves, freeze-dry them, crush them, thaw them at room temperature and concentrate them to a relative density of 1.10-1.20, spray-dry the concentrated solution, and perform CO2 supercritical extraction. The fluid extraction pressure is 30-50MPa, and the extraction temperature is 30-40°C. The CO 2 fluid flow rate is 750-850L/h, and the extraction time is 3-5h to obtain olive leaf extract.
其中,所述葛仙米发酵粉通过以下步骤制备所得:Wherein, the kudzu rice fermented powder is prepared through the following steps:
取洗净沥干后的葛仙米置于汽爆罐内,先通入氮气至汽爆罐内压力为0.7-1.5MPa,爆破处理7-23min;然后迅速通入蒸汽至汽爆罐内压力为1.5-2.1MPa,蒸汽爆破处理0.8-2.8min后,按照接种量1.5-1.7%的比例接种微生物发酵剂,保持温度25-35℃,发酵48-54小时后,高温灭菌,得葛仙米发酵粉。Take the washed and drained kudzu rice and put it in the steam explosion tank, first pass nitrogen gas until the pressure in the steam explosion tank is 0.7-1.5MPa, and blast for 7-23 minutes; then quickly inject steam to the pressure in the steam explosion tank 1.5-2.1MPa, after steam explosion treatment for 0.8-2.8min, inoculate the microbial starter according to the proportion of 1.5-1.7% of the inoculum, keep the temperature at 25-35°C, ferment for 48-54 hours, and then sterilize at high temperature to obtain kudzu Rice Baking Powder.
其中,所述微生物发酵剂由乳酸杆菌、地衣芽孢杆菌、谷氨酸棒杆菌按质量比3∶2∶1混合所得。Wherein, the microbial starter is obtained by mixing Lactobacillus, Bacillus licheniformis and Corynebacterium glutamicum in a mass ratio of 3:2:1.
其中,所述破壁灵芝孢子粉通过以下步骤制备所得:Wherein, the broken ganoderma spore powder is prepared through the following steps:
S1、将洗净沥干的灵芝孢子置于汽爆罐内,先通入氮气至汽爆罐内压力为0.6-1.4MPa,爆破处理8-25min;然后迅速通入蒸汽至汽爆罐内压力为1.4-1.8MPa,蒸汽爆破处理0.5-2.5min后,室温浓缩至相对密度1.10-1.20,喷雾干燥浓缩液,得粉体;S1. Put the washed and drained Ganoderma lucidum spores in the steam explosion tank, first feed nitrogen until the pressure in the steam explosion tank is 0.6-1.4MPa, and blast for 8-25 minutes; then quickly inject steam to the pressure in the steam explosion tank 1.4-1.8MPa, steam explosion treatment for 0.5-2.5min, concentrated at room temperature to a relative density of 1.10-1.20, spray-dried the concentrate to obtain powder;
S2、向粉体中加入3-8倍水,按质量百分比为2-3%的比例加入中性蛋白酶,按质量百分比为1-2%加入风味蛋白酶,30-50℃下酶解1-2h,过滤,得酶解液;S2. Add 3-8 times of water to the powder, add neutral protease at a mass percentage of 2-3%, add flavor protease at a mass percentage of 1-2%, and enzymatically hydrolyze at 30-50°C for 1-2 hours , filtered to obtain the enzymatic solution;
S3、将所得的发酵液迅速冷冻后再自然解冻,使提取物中淀粉老化沉淀;收集上清液,剩余部分离心,收集离心液体并合并于上清液中;S3, rapidly freezing the obtained fermented liquid and then thawing naturally to age and precipitate the starch in the extract; collecting the supernatant, centrifuging the remaining part, collecting the centrifuged liquid and merging it into the supernatant;
S4、将上清液以3-7BV/h的流速通过大孔树脂柱,动态吸附饱和后,用去离子水以5-8BV/h的流速淋洗上述大孔树脂柱至流出液无色,再用体积分数为50%-70%的有机溶剂以8-12BV/h的流速进行洗脱,收集洗脱液,冷冻干燥,得破壁灵芝孢子粉。S4. Pass the supernatant through the macroporous resin column at a flow rate of 3-7BV/h. After the dynamic adsorption is saturated, rinse the above-mentioned macroporous resin column with deionized water at a flow rate of 5-8BV/h until the effluent is colorless. Then use an organic solvent with a volume fraction of 50%-70% for elution at a flow rate of 8-12BV/h, collect the eluate, and freeze-dry to obtain the broken-wall ganoderma spore powder.
实施例1Example 1
一种用于激活线粒体的组合物,由以下重量份的原料制备而成:A composition for activating mitochondria, prepared from the following raw materials in parts by weight:
香豆雌酚10份、辅酶Q10 5份、鞣花酸10份、槲皮素1份、葡萄籽提取物5份、奶蓟草提取物10份、橄榄叶提取物10份、琉璃苣10份、葛仙米发酵粉3份、破壁灵芝孢子粉4份、乙酰肉碱10份、山核桃树皮超微粉碎粉5份。10 parts coumestrol, 5 parts coenzyme Q10, 10 parts ellagic acid, 1 part quercetin, 5 parts grape seed extract, 10 parts milk thistle extract, 10 parts olive leaf extract, 10 parts borage , 3 parts of kudzu rice fermentation powder, 4 parts of broken ganoderma spore powder, 10 parts of acetylcarnitine, 5 parts of hickory bark superfine powder.
实施例2Example 2
一种用于激活线粒体的组合物,由以下重量份的原料制备而成:A composition for activating mitochondria, prepared from the following raw materials in parts by weight:
香豆雌酚20份、辅酶Q10 10份、鞣花酸20份、槲皮素3份、葡萄籽提取物10份、奶蓟草提取物15份、橄榄叶提取物15份、琉璃苣15份、葛仙米发酵粉6份、破壁灵芝孢子粉8份、乙酰肉碱15份、山核桃树皮超微粉碎粉10份。20 parts of coumestrol, 10 parts of coenzyme Q10, 20 parts of ellagic acid, 3 parts of quercetin, 10 parts of grape seed extract, 15 parts of milk thistle extract, 15 parts of olive leaf extract, 15 parts of borage , 6 parts of kudzu rice fermentation powder, 8 parts of broken ganoderma spore powder, 15 parts of acetylcarnitine, 10 parts of hickory bark superfine powder.
实施例3Example 3
一种用于激活线粒体的组合物,由以下重量份的原料制备而成:A composition for activating mitochondria, prepared from the following raw materials in parts by weight:
香豆雌酚15份、辅酶Q10 7.5份、鞣花酸15份、槲皮素2份、葡萄籽提取物7.5份、奶蓟草提取物12.5份、橄榄叶提取物12.5份、琉璃苣12.5份、葛仙米发酵粉4.5份、破壁灵芝孢子粉6份、乙酰肉碱12.5份、山核桃树皮超微粉碎粉7.5份。15 parts of coumestrol, 7.5 parts of coenzyme Q10, 15 parts of ellagic acid, 2 parts of quercetin, 7.5 parts of grape seed extract, 12.5 parts of milk thistle extract, 12.5 parts of olive leaf extract, 12.5 parts of borage , 4.5 parts of kudzu rice fermentation powder, 6 parts of broken Ganoderma lucidum spore powder, 12.5 parts of acetylcarnitine, 7.5 parts of hickory bark superfine powder.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以作出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications should also be It is regarded as the protection scope of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710204579.7A CN106924456A (en) | 2017-03-26 | 2017-03-26 | One kind is for activating mitochondrial composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710204579.7A CN106924456A (en) | 2017-03-26 | 2017-03-26 | One kind is for activating mitochondrial composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106924456A true CN106924456A (en) | 2017-07-07 |
Family
ID=59425205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710204579.7A Pending CN106924456A (en) | 2017-03-26 | 2017-03-26 | One kind is for activating mitochondrial composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106924456A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110237106A (en) * | 2018-03-07 | 2019-09-17 | 台湾粒线体应用技术股份有限公司 | Ganoderma lucidum extract is used to prepare the purposes for improving bio-energy health index and the medical composition for promoting cell to be broken up |
| CN111982763A (en) * | 2020-08-17 | 2020-11-24 | 上海普康药业有限公司 | Method for determining particle size and particle size distribution of coenzyme Q10 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920194A (en) * | 2016-04-24 | 2016-09-07 | 新乡医学院 | Anti-tumor traditional Chinese medicinal agent |
| CN106265459A (en) * | 2016-10-09 | 2017-01-04 | 上海兰葹生物科技有限公司 | A kind of Herba Dendrobii promotes skin regeneration combination anti-senile preparation |
| CN106309329A (en) * | 2016-10-09 | 2017-01-11 | 上海兰葹生物科技有限公司 | Dendrobe combined eye cream for promoting skin regeneration |
| CN106490608A (en) * | 2016-10-09 | 2017-03-15 | 上海兰葹生物科技有限公司 | A kind of Herba Dendrobii enhancing immunity oral liquid, electuary, capsule, tablet |
-
2017
- 2017-03-26 CN CN201710204579.7A patent/CN106924456A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920194A (en) * | 2016-04-24 | 2016-09-07 | 新乡医学院 | Anti-tumor traditional Chinese medicinal agent |
| CN106265459A (en) * | 2016-10-09 | 2017-01-04 | 上海兰葹生物科技有限公司 | A kind of Herba Dendrobii promotes skin regeneration combination anti-senile preparation |
| CN106309329A (en) * | 2016-10-09 | 2017-01-11 | 上海兰葹生物科技有限公司 | Dendrobe combined eye cream for promoting skin regeneration |
| CN106490608A (en) * | 2016-10-09 | 2017-03-15 | 上海兰葹生物科技有限公司 | A kind of Herba Dendrobii enhancing immunity oral liquid, electuary, capsule, tablet |
Non-Patent Citations (2)
| Title |
|---|
| 于守洋等: "《中国保健食品的进展》", 31 January 2001, 人民卫生出版社 * |
| 汪多仁: "《绿色医药化学品》", 31 July 2008, 科学技术文献出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110237106A (en) * | 2018-03-07 | 2019-09-17 | 台湾粒线体应用技术股份有限公司 | Ganoderma lucidum extract is used to prepare the purposes for improving bio-energy health index and the medical composition for promoting cell to be broken up |
| CN111982763A (en) * | 2020-08-17 | 2020-11-24 | 上海普康药业有限公司 | Method for determining particle size and particle size distribution of coenzyme Q10 |
| CN111982763B (en) * | 2020-08-17 | 2021-05-14 | 上海普康药业有限公司 | Method for determining particle size and particle size distribution of coenzyme Q10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101392011A (en) | A kind of separation and purification method of natural salidroside | |
| CN104710525A (en) | Tuna fishbone collagen sourced zinc chelated collagen peptide, preparation method and application thereof | |
| CN104262413B (en) | Preparation method of trehalose anhydrous | |
| CN107252093B (en) | Guava leaf rich in soluble polyphenol and flavonoid aglycone, preparation method and application | |
| CN103013936A (en) | Method for extracting anthocyanidin by using compound enzyme, and compound enzyme preparation thereof | |
| CN104887718B (en) | A kind of preparation method of alpha-glucosidase restrainer | |
| CN107149145A (en) | A kind of bark of eucommia fatigue resistant health food and preparation method thereof | |
| CN105418693B (en) | The application of the extracting method of tannin and its gained tannin in a kind of walnut shell | |
| WO2020042557A1 (en) | Method for extracting citrulline from watermelon | |
| CN106924456A (en) | One kind is for activating mitochondrial composition | |
| CN104083534A (en) | Method for preparing procyanidine of camellia seed shell | |
| Liu et al. | Comparison of different drying pretreatment combined with ultrasonic-assisted enzymolysis extraction of anthocyanins from Lycium ruthenicum Murr. | |
| CN103074321B (en) | Immobilized compound enzyme and method for treating alliin waste liquid by using same | |
| CN116496339B (en) | Industrial production method of Siraitia grosvenorii extract without pesticide residues | |
| CN107840839B (en) | A kind of blueberry leaf anthocyanidin aqueous two-phase extraction combination forward osmosis concentration extraction technology | |
| CN101845464A (en) | Method for preparing ferulic acid by utilizing corn bran hydrolyzed by multifunctional enzyme | |
| CN114366760A (en) | Application of Artemisia annua polyphenols in the preparation of medicaments for the treatment of diabetes and preparation method thereof | |
| CN108497378A (en) | A kind of black fruit fructus lycii instant powder and its preparation method and application | |
| CN107383152A (en) | The preparation method of golden flower Tea Saponins | |
| CN106860490A (en) | A kind of preparation technology of the pomegranate peel polyphenol of anti-fatigue active | |
| CN105331655A (en) | Tea seed oligosaccharide and preparing method thereof | |
| CN104497102B (en) | A kind of pig brain polypeptide for preventing and treating the nervous system disease and preparation method thereof | |
| CN106259850B (en) | It is able to suppress the storage practice of potato reduction sugar accumulation | |
| CN117159649A (en) | Dendrobium traditional Chinese medicine composition and preparation method thereof | |
| CN111961024B (en) | Method for preparing epigallocatechin gallate and application of epigallocatechin gallate in anti-sugar products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170707 |
|
| RJ01 | Rejection of invention patent application after publication |